Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-10 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | BRSK1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |